YK-029A

Cat. No. M42078

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

YK-029A is an orally active inhibitor of mutant EGFR, targeting to both the T790M mutations (EGFRT790M) and exon 20 insertion of EGFR (EGFRex20ins).

Molecular Weight	500.6
Formula	C27H32N8O2
CAS Number	2064269-82-3
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related EGFR/HER2 Products
Sevabertinib Sevabertinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor with antitumor activity.
BPIQ-I BPIQ-I (PD 159121) is a potent and ATP-competitive EGFR tyrosine kinase inhibitor..
HKI-357 HKI-357 is an irreversible dual inhibitor of EGFR and ERBB2 with IC50s of 34 nM and 33 nM, respectively.
SJF-1528 SJF-1528 is a potent EGFR PROTAC degrader with DC50 values of 39.2 nM and 736.2 nM for wild-type EGFR in OVCAR8 cells and Exon 20 Ins mutated EGFR in HeLa cells.
CH7233163 CH7233163 is a noncovalent ATP-competitive inhibitor for EGFR-Del19/T790M/C797S.

Catalog